Effect of fondaparinux 2.5 mg once daily on mortality: a meta-analysis of phase III randomized trials of venous thromboembolism prevention
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 1, 2008
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- Cardiovascular System & Hematology (Science Metrix)